Table 3

Most frequent adverse events occurring in >2% of women in either regimen (full analysis set)

FlexibleMIBConventional
Adverse eventEvents (n)Subjects [n(%)]Events (n)Subjects [n(%)]
Headache76 (5.2)106 (5.6)
Nasopharyngitis88 (7.0)44 (3.7)
Breast pain33 (2.6)44 (3.7)
Vaginal infection55 (4.3)22 (1.9)
Diarrhoea44 (3.5)22 (1.9)
Vomiting22 (1.7)54 (3.7)
Cystitis22 (1.7)53 (2.8)
Acne33 (2.6)11 (0.9)
  • MIB, management of intracyclic (breakthrough) bleeding.